Clinical trial

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

NCT00455403

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Chloroquine Normalized identity: chloroquineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Comparator Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-04-01

PhaseNA

Conditions

Metabolic Syndrome Xverified · MONDO: metabolic syndrome X

Overweightunresolved

Hypertensionunresolved

Dyslipidemiasunresolved

Prediabetic Stateunresolved

Interventions

ChloroquineDRUG · verified · RxNorm: chloroquine

Placebo ComparatorDRUG

Sponsors & collaborators

Washington University School of Medicinelead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Singulexcollaborator

Mapped research locations

St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00455403 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.